• Return to Headlines

17.8% Return Seen to Date on SmarTrend Aimmune Therapeu Call (AIMT)

By David Diaz

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 2 months, Aimmune Therapeu has returned 17.83% as of today's recent price of $29.14.

In the past 52 weeks, Aimmune Therapeu share prices have been bracketed by a low of $16.95 and a high of $36.12 and are now at $29.14, 72% above that low price. The 200-day and 50-day moving averages have moved 0.16% higher and 1.74% higher over the past week, respectively.

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Aimmune Therapeu shares.

Log in and add Aimmune Therapeu (AIMT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights aimmune therapeu

Ticker(s): AIMT